Answers are grounded in this paper and cite their sources.
Diagnostic target selection must account for sequence variation, target loss, taxonomic coverage, and viral genome structure. This selective narrative review compares evidence from Chlamydiatrachomatis, Gardnerella spp., Ureaplasma urealyticum, and HPV16 to identify implications for TaqMan PCR design, validation, and reporting. Documented chlamydial escape variants demonstrate that complementary targets must address a specified failure mechanism and preserve detection under the assay’s reporting rule. Gardnerella studies show that the reported taxon must match the species groups actually detected, while Ureaplasma assays require both within-species inclusivity and discrimination from U. parvum. HPV comparisons do not establish universal superiority of E6/E7 over L1 and show why assay discordance alone cannot demonstrate regional target loss. The review links these findings to case-specific validation material and illustrates their application in a dual-target chlamydial design. The resulting recommendations distinguish correction of an inaccurate reporting label, additional testing of incompletely represented populations, and modification of an assay with confirmed detection failure. Evidence from different assay chemistries and clinical endpoints is interpreted separately; the proposed validation approach has not been prospectively evaluated.
No takes yet. Share an insight, caveat, or question.
Aktayeva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: